Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Fraxiparine now listed on Canadian health plan formularies

April 30, 1998

Aspirin versus warfarin for the prevention of stroke in patients with atrial fibrillation

April 29, 1998

Phase I data reported for Vasoflux at ACC meeting in Rio

April 28, 1998

Orbofiban: a fibrinogen antagonist for the treatment of acute coronary syndromes

April 28, 1998

t-PA treatment may be beneficial to stroke patients and health care systems

April 28, 1998

New hirudin option now available in U.K.

April 27, 1998

Markers of thrombin and their relation to clinical outcome after myocardial infarction

April 23, 1998

Effects of aspirin + ticlopidine combination antiplatelet therapy following stent implantation

April 20, 1998

Genentech claims TF-FVIIa hybrids for coagulation disorders

April 16, 1998

Benefits of abciximab therapy in coronary stent deployment and coronary angioplasty

April 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...